Physician profile
Tyler B Keenum
NPI 1073041505
$10,082.44
in general payments reported to CMS, 2019-2025
5 companies · $6,488 in 2025
The $6,488 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $978 · 2022: $921 · 2023: $737 · 2024: $958 · 2025: $6,488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,450 · Food and Beverage: $2,959 · Travel and Lodging: $1,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,450.00 |
| Food and Beverage | $2,958.76 |
| Travel and Lodging | $1,774.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $6,644.42 | 2021-2025 | Yeztugo, Biktarvy, Descovy |
| Viiv Healthcare Company | $2,986.91 | 2021-2025 | Dovato, Apretude, Cabenuva |
| Merck Sharp & Dohme LLC | $393.17 | 2021-2025 | Pifeltro, Delstrigo |
| Hologic Sales and Service, LLC | $43.54 | 2022-2023 | Aptima |
| Janssen Biotech, INC. | $14.40 | 2023 | Symtuza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Keenum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.